ANNOUNCEMENT OF TENDER RESULTS – Request For Proposal No. 03/2023-ABM
OBJECT FOR THE REQUEST: Preparation and comprehensive execution of the phase II, Proof-of-Concept, clinical trial in order to assess efficacy, pharmacokinetics, pharmacodynamics and safety of chitinase inhibitor OATD-01 in patients with active pulmonary sarcoidosis.
After collecting all the information regarding the request for proposal and after analyzing the completeness of the offers, the Tender Commission concludes that the most advantageous offer meeting all the requirements contained in the request has been presented by:
Orion Santé Sarl
Centre d’Affaires La Boursidière, Bâtiment le Jura, 2ème étage,
BP 141, 92357, Le Plessis Robinson cedex, France
Total net price of the order execution: 10,060,495.52 EUR
The Commission recommends the Management Board to perform the order in accordance with the offer submitted by this Contractor.